You are here

General articles on Gastrointestinal Cancer

This section of the Advances in Gastrointestinal Cancer Resource Centre is where you will find cutting edge data on gastrointestinal cancers in the form of peer-reviewed original articles and review articles and the latest guidelines, all independently selected and several commented upon by members of the Editorial Board. Many of the articles are freely available for downloading.

Focusing initially on gastric cancer, these pages will provide new content each month to help you stay abreast of recent scientific developments in this area. 

Since 1975, stomach cancer has dropped from first position to fifth in the list of most common cancers in the world, after lung, breast, colorectal, and prostate cancers.1 In most of the world, however, few cases of stomach cancer are detected at an early stage, and 5-year survival rates range from less than 20% in developing countries to 54% in Japan, where a national screening programme facilitates earlier detection and treatment.2

Treatment approaches for stomach cancer include chemotherapy, radiation therapy, targeted therapy, immunotherapy, and surgery. Much research is under way to identify new therapeutic options.

To stay abreast of the most recent developments in the epidemiology and treatment of gastrointestinal cancers, please subscribe to our eAlert to ensure you are informed of all new content as it is published on this platform.


1. International Agency for Research on Cancer. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. Available from: Accessed 6 April 2016.
2. American Cancer Society. Global Cancer Facts & Figures. 3rd edition. Atlanta: American Cancer Society; 2015.


Search this site

Search form

ECCO2017 symposium webcast: Treatment evolution in advanced GI malignancies

Welcome and introduction - Florian Lordick


Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Featured Content

New Book Content

This online Resource Centre has been sponsored by Lilly Oncology

Note that Lilly Oncology has no editorial control over the content of this Resource Centre. The Resource Centre and all content therein has been subject to an independent editorial review.